Natural Killer p46 Controls Hepatitis B Virus Replication and Modulates Liver Inflammation.
Natural killer (NK) cells play an important role in hepatitis B virus (HBV) infection control, and are regulated by a complex network of activating and inhibitory receptors. However, NK cell activity in HBV patients remains poorly understood. The objective of this study was to investigate the phenotypic and functional characteristics of circulating NK cells in patients during different chronic hepatitis B (CHB) infection stages. We investigated NK cell phenotypes, receptor expression and function in 86 CHB patients and 20 healthy controls. NK cells were purified and NK cell subsets were characterized by flow cytometry. Cytotoxic activity (CD107a) and interferon-gamma (IFN-γ) secretion were examined, and Natural Killer p46 (NKP46) blockade and spontaneous NK cell cytolytic activity against K562, HepG2 and HepG2.215 cell lines was studied. Activating NKp46 receptor expression was higher in inactive HBsAg carriers when compared with other groups (p = 0.008). NKp46 expression negatively correlated with HBV DNA (R = -0.253, p = 0.049) and ALT (R = -0.256, p = 0.045) levels. CD107a was higher in immune-activated groups when compared with immune-tolerant groups (p = 0.039). CD107a expression was related to viral load (p = 0.02) and HBeAg status (p = 0.024). In vitro NKp46 blockade reduced NK cell cytolytic activity against HepG2 and HepG2.215 cell lines (p = 0.02; p = 0.039). Furthermore, NK cells from high viral load CHB patients displayed significantly lower specific cytolytic activity against anti-NKp46-loaded K562 targets (p = 0.0321). No significant differences were observed in IFN-γ secretion (p > 0.05). In conclusion, NKp46 expression regulates NK cell cytolytic function. NKp46 may moderate NK cell activity during HBV replication suppression and HBV-associated liver damage and may be critical for NK cell activity during CHB infection.
Department of Hepatology, First Hospital, Jilin University, No. 71 Xinmin Street, Changchun, 130021, China.
Wanyu
W
Li
Department of Hepatology, First Hospital, Jilin University, No. 71 Xinmin Street, Changchun, 130021, China.
Yanfang
Y
Jiang
Department of Hepatology, First Hospital, Jilin University, No. 71 Xinmin Street, Changchun, 130021, China.
Xiaomei
X
Wang
Department of Hepatology, First Hospital, Jilin University, No. 71 Xinmin Street, Changchun, 130021, China.
Jinglan
J
Jin
Department of Hepatology, First Hospital, Jilin University, No. 71 Xinmin Street, Changchun, 130021, China.
Yue
Y
Qi
Department of Hepatology, First Hospital, Jilin University, No. 71 Xinmin Street, Changchun, 130021, China.
Xiumei
X
Chi
Department of Hepatology, First Hospital, Jilin University, No. 71 Xinmin Street, Changchun, 130021, China.
Hong
H
Zhang
Department of Hepatology, First Hospital, Jilin University, No. 71 Xinmin Street, Changchun, 130021, China.
Xiangwei
X
Feng
Department of Hepatology, First Hospital, Jilin University, No. 71 Xinmin Street, Changchun, 130021, China.
Junqi
J
Niu
D000328:Adult; D016022:Case-Control Studies; D045744:Cell Line, Tumor; D004279:DNA, Viral / Q000276:immunology; D005260:Female; D056945:Hep G2 Cells; D006513:Hepatitis B e Antigens / Q000276:immunology; D006515:Hepatitis B virus / Q000276:immunology*; D019694:Hepatitis B, Chronic / Q000276:immunology / Q000821:virology; D006801:Humans; D007249:Inflammation / Q000276:immunology* / Q000821:virology; D007371:Interferon-gamma / Q000276:immunology; D020014:K562 Cells; D007694:Killer Cells, Natural / Q000276:immunology* / Q000821:virology; D008099:Liver / Q000276:immunology* / Q000821:virology; D008297:Male; D055627:Natural Cytotoxicity Triggering Receptor 1 / Q000276:immunology*; D019562:Viral Load / Q000276:immunology; D014779:Virus Replication / Q000276:immunology*
D004279:DNA, Viral; D006513:Hepatitis B e Antigens; D055627:Natural Cytotoxicity Triggering Receptor 1; D007371:Interferon-gamma